Delivery Order SPE2DB20D2104-SPE2DB25FMZGF
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, for $43,155.50 (ceiling value) to supply Zepbound 15 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and was awarded competitively without a set-aside designation. The place of performance is the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $27,920 on August 25, 2025, by the Medical Supply Chain division of the Defense Logistics Agency. The contract, which represents a child order under a larger Indefinite Delivery Contract framework, calls for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pre-filled pens. This is a firm fixed price, competitively awarded delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $7,625.80. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by August 5, 2025, with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency Medical Supply Chain valued at $4,383.54 for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed price, non-set-aside contract was awarded on July 30, 2025, with a completion date of July 31, 2025. The delivery order represents a continuation of the company's substantial pharmaceutical supply relationship with the Defense Logistics Agency,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $27,799.20 from the Defense Logistics Agency's Medical Supply Chain on August 15, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is set to be completed by August 18, 2025, and work will be performed at the vendor's Conshohocken facility. This delivery order...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $60,245.30 from the Defense Logistics Agency's Medical Supply Chain on September 2, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 3, 2025, with performance taking place at the company's Conshohocken facility. The delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections with a contract ceiling value of $9,618.39. This is a firm fixed-price delivery order with no set-aside designation, demonstrating the contractor's ability to compete successfully in open procurement. The order is set for completion by August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,060.31 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $13,474.62 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed price delivery order, which is not set-aside designated, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZGFDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on September 2, 2025, for Zepbound 5 mg/0.5 mL pen injections. This firm fixed price delivery order, valued at $5,405.58, was awarded without set-aside provisions and is scheduled for completion by September 3, 2025. The order will be fulfilled at the contractor's Conshohocken location and represents a small-value transaction within the company's extensive federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems globally. The IDC enables DLA to procure medications across multiple therapeutic domains through delivery orders such as this one, supporting Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's competitive award history with DLA demonstrates its capability to meet federal procurement standards for critical pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/2/25 |